GM-CSF: Clinical Trials

7 trials of GM-CSF, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 5, Not yet recruiting 1, Unknown 1

Follow GM-CSF: new trials by email Literature Review of GM-CSF trials Research Report on GM-CSF

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.
Naxitamab - Neuroblastoma
Phase 4Not yet recruitingSciClone Pharmaceuticals622023-10-312023-09-21
GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study
GM-CSF - Pediatric Sepsis-induced MODS
Phase 4CompletedNationwide Children's Hospital752018-12-052026-05-05
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
GM-CSF, G-CSF, GM-CSF and G-CSF - Acute Myeloid Leukemia, Acute Lymphoid Leukemia
Phase 4UnknownXinhua Hospital, Shanghai Jiao Tong University School of Medicine4052016-09-272018-10-17
Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma
GM-CSF, Standard of Care - Melanoma
Phase 4CompletedMayo Clinic82015-05-012020-02-10
Effects of Embryogen in RIF Patients
GM-CSF - Infertility
Phase 4CompletedVietnam National University602013-07-012014-09-26
GM-CSF for Immunomodulation Following Trauma (GIFT) Study
GM-CSF - Critical Injury (Trauma) in Children
Phase 4CompletedMark Hall1082011-12-012023-09-13
Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).
HAART, HAART + Immunotherapy - HIV
Phase 4CompletedJuan A. Arnaiz222005-03-012014-11-19

Conditions studied

Neuroblastoma (2)  ·  Hepatoblastoma (1)  ·  Infertility (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma (1)  ·  Melanoma (1)  ·  Multiple Organ Failure (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Retinoblastoma (1)  ·  Sepsis (1)  ·  Wounds and Injuries (1)

Sponsors

Juan A. Arnaiz (1)  ·  Mark Hall (1)  ·  Mayo Clinic (1)  ·  Nationwide Children's Hospital (1)  ·  SciClone Pharmaceuticals (1)  ·  Vietnam National University (1)  ·  Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

United States (3)  ·  China (1)  ·  Spain (1)  ·  Vietnam (1)

Top investigators

Mark W Hall, MD (2)  ·  Fang Yongjun, Ph.D (1)  ·  Gao Fei, Ph.D (1)  ·  Hu Shaoyan, Ph.D (1)  ·  James Jakub, MD (1)  ·  Li Aimin, Ph.D (1)  ·  Liang Changda, Master (1)  ·  Liu Wei, Ph.D (1)  ·  Pan Kaili, Master (1)  ·  Sun Lirong, Ph.D (1)  ·  Vinh Q Dang, Dr (1)  ·  Wang Hongmei, Ph.D (1)  ·  Wen Hong, Ph.D (1)  ·  Yuan Xiaojun, Ph.D (1)

Results publications

PMID 27999018

NIH funding

R01GM094203 (1), UG1HD083170 (1)